ActiveCONTRACT

Custom MHC Class II HLA-DP Xynapse and Dextramer R

NATIONAL INSTITUTES OF HEALTHHEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO

AI Overview

Procurement of custom MHC Class II HLA-DP Xynapse and Dextramer reagents for liver cancer neoantigen validation and immunological research.

This summary is AI-generated from the official solicitation.

Key Details

Agency
NATIONAL INSTITUTES OF HEALTH
Funding Amount
—
Release Date
July 14, 2026
Due Date
July 22, 2026

Official Description

Custom MHC Class II HLA-DP Xynapse and Dextramer Reagents for Liver Cancer Neoantigen Validation

⚠️ Note: The SAM.gov API does not provide detailed information for this opportunity. Full details may be available in attached documents or by contacting the point of contact directly.

View on official source

Change History

Opportunity AddedJul 14, 2026 at 1:03 PM

Custom MHC Class II HLA-DP Xynapse and Dextramer R

New SAM.gov opportunity: Custom MHC Class II HLA-DP Xynapse and Dextramer R

Similar Opportunities

Forecast

Histopathology and antibody screening of Hutchinson Gilford progeria syndrome mouse model DNA editing therapeutic preclinical trial samples.

Due July 20, 2026

Active

Posit Renewal

Due July 16, 2026

Forecast

R--Sequencing 389 TNA Samples

Due July 20, 2026

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial